Abstract
The Hodgkin's-like Type B neoplasms which arise spontaneously in aging C57L mice (25% incidence at 21 months of age) were first reported over 40 years ago, but since then relatively little has been published about these lymphomas. Based on previous studies in SJL mice, we investigated the phenotypic and functional properties of C57L-derived lymphomas in relation to Mtv29-encoded vSAg expression by the tumor cells, and their ability to stimulate TCR Vβ-restricted T cells. The cell surface phenotype of the C57L lymphomas indicates a B cell origin (sIg+, MHC II+). These B lymphoma cells also express co-stimulatory molecules [B7-1 (CD80) and HSA (CD24)], and stimulate marked proliferation of syngeneic CD4+ T cells. C57L B lymphoma cells exhibit Mtv-encoded mRNA by northern analysis, and also stimulate IL-2 production from Vβ16+ T cell hybrids, suggesting a role for Mtv 29 in this syngeneic T cell response. After transfer to syngeneic recipients, primary C57L lymphomas grow slowly, if at all. However, tumor growth is greatly accelerated by pretreatment of C57L recipients with anti-asialo GM1 antibody (but not anti-CD8 mAb), suggesting that NK cells play a major role in inhibiting lymphoma growth. If, in addition to anti-asialo GM1, the mice are also pretreated with anti-CD4 mAb, tumor growth is markedly inhibited, indicating that the lymphoma-responsive syngeneic CD4+ T cells promote tumor growth. Therefore, although the vSAg-induced response stimulated by vSAg29 expressing lymphoma cells in syngeneic TCR Vβ-restricted CD4+ T cells is an important etiologic factor in this type of B cell neoplasm both in C57L and in SJL mice, the final outcome of the spontaneous neoplastic process appears strongly influenced by endogenous NK activity in aging mice. Copyright (C) 2000 Elsevier Science Ltd.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 705-718 |
| Number of pages | 14 |
| Journal | Leukemia Research |
| Volume | 24 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2000 |
Funding
The authors wish to thank Dr Y. Liu (NYU Medical Center; New York, NY), Dr David Woodland (St Jude Children’s Research Hospital; Memphis, TN), and Dr Stephen Lerman (Wayne State University School of Medicine; Detroit, MI) for sharing their reagents and cell lines with us. We also thank Dana Stein and staff members of the UMDNJ-NJMS Flow Cytometry facility for help with the cell surface phenotype analysis, and the staff of the UMDNJ Research Animal Facility for the excellent care of the laboratory animals used in this study. Special thanks are extended to Dr G.J. Thorbecke (NYU Medical Center) and Drs E. Raveche and P. Rameshwar (UMDNJ-NJMS) for critical review of this manuscript, and to Joan Koch for help in its preparation. This work was supported, in part, by grants from the New Jersey State Commission on Cancer Research, the Foundation of UMDNJ, DHHS grant CA 14462, and the Cancer Research Institute. G. Erianne provided the concept, design, analysis of data, drafting of the paper, critical revision, logistical support, assembly of data, statistical expertise and gave final approval, J. Wajehman helped to collect, assemble the data, provided technical support and data analyysis. R. Yauch provided study materials, collected the data and gave technical support. V. Tsiagbe assembled the data and gave technical support. B. Kim provided study materials. N.M. Ponzio contributed to the concept, design, provided statistical input for analysis and interpretation of the data, assisted in drafting and revising the paper, obtained funding and gave final approval.
Keywords
- Lymphomagenesis
- Mammary tumor virus
- Superantigens
- Tumor immunity
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
